Highlights
NASDAQ: VTGN       Vistagen Therap. Com
Last Price Today's Change   Day's Range   Trading Volume
0.435   +0.005 (1.16%)  0.421 - 0.45  144,100

Overview

 
Avg Volume (4 weeks):859,608
4 Weeks Range:0.29 - 1.147
4 Weeks Price Volatility (%):
16.92%
52 Weeks Range:0.29 - 1.86
52 Weeks Price Volatility (%):
9.24%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers